Shikimate Pathway Variants
莽草通路变异体
基本信息
- 批准号:6465605
- 负责人:
- 金额:$ 28.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2006-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Some of the more interesting aspects of
natural product biosynthesis are the variations on common themes. A case in
point is the shikimate pathway. Starting with the condensation of
phosphoenolpyruvate with D-erythrose 4-phosphate, the shikimate pathway has
been the focus of intense scrutiny.
One variant of the shikimate pathway is found in Amycolatopsis mediterranei
where 1-imino-1-deoxy-D-erythrose 4-phosphate replaces D-erythrose 4-phosphate
as the likely starting point of what has been named the aminoshikimate pathway.
The hypothesis that 3-amino-3-deoxy-D-fructose 6-phosphate is the source of
1-imino-1-deoxy-D-erythrose 4-phosphate will be explored. In turn, the
biosynthesis of 3-amino-3-deoxy-D-fructose 6-phosphate is to be elaborated.
Beyond answering fundamental biosynthetic questions associated with the source
of the nitrogen atom utilized by the aminoshikimate pathway, proposed research
could ultimately lead to a biocatalytic route to aminoshikimic acid suitable
for use in the synthesis of anti-influenza agents.
A second variant of the shikimate pathway is to be created in Escherichia coli
where phosphoenolpyruvate will be replaced by pyruvate as the three-carbon
metabolite condensed with D-erythrose 4-phosphate. This will require
recruitment of native and evolved 2-keto-3-deoxy-6-phosphogalactonate aldolase
to catalyze the condensation of pyruvate with D-erythrose 4-phosphate.
Initiating the shikimate pathway with the condensation of pyruvate with
D-erythrose 4-phosphate could substantially improve the yields of
pharmaceutically important molecules microbially synthesized by way of this
pathway and may serve as a paradigm of shikimate pathway variants employed by
microbes under anaerobic growth conditions.
描述(由申请人提供):一些更有趣的方面
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN W FROST其他文献
JOHN W FROST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN W FROST', 18)}}的其他基金
MICROBIAL BIOCATALYST DESIGN--SHIKIMIC ACID SYNTHESIS
微生物生物催化剂设计--莽草酸合成
- 批准号:
2903207 - 财政年份:1999
- 资助金额:
$ 28.23万 - 项目类别:
MICROBIAL BIOCATALYST DESIGN--SHIKIMIC ACID SYNTHESIS
微生物生物催化剂设计--莽草酸合成
- 批准号:
6180847 - 财政年份:1999
- 资助金额:
$ 28.23万 - 项目类别:
MICROBIAL BIOCATALYST DESIGN--SHIKIMIC ACID SYNTHESIS
微生物生物催化剂设计--莽草酸合成
- 批准号:
6386381 - 财政年份:1999
- 资助金额:
$ 28.23万 - 项目类别:
MICROBIAL BIOCATALYST DESIGN--SHIKIMIC ACID SYNTHESIS
微生物生物催化剂设计--莽草酸合成
- 批准号:
6525498 - 财政年份:1999
- 资助金额:
$ 28.23万 - 项目类别:
相似国自然基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
- 批准号:32302245
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
- 批准号:82371775
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
- 批准号:31871817
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
- 批准号:81873549
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
- 批准号:31571933
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
- 批准号:31371861
- 批准年份:2013
- 资助金额:15.0 万元
- 项目类别:面上项目
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
- 批准号:31371845
- 批准年份:2013
- 资助金额:15.0 万元
- 项目类别:面上项目
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
- 批准号:31171774
- 批准年份:2011
- 资助金额:66.0 万元
- 项目类别:面上项目
相似海外基金
Knowledgebase of Escherichia coli Genome and Metabolism
大肠杆菌基因组和代谢知识库
- 批准号:
10716050 - 财政年份:2023
- 资助金额:
$ 28.23万 - 项目类别:
Copper Sensing in Uropathogenic Escherichia coli
尿路致病性大肠杆菌中的铜感应
- 批准号:
10604449 - 财政年份:2023
- 资助金额:
$ 28.23万 - 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
- 批准号:
10747651 - 财政年份:2023
- 资助金额:
$ 28.23万 - 项目类别:
Inactivation of Escherichia coli using high hydrostatic pressure from viewpoints of cell shrinkage and expansion
从细胞收缩和扩张的角度利用高静水压灭活大肠杆菌
- 批准号:
23K05105 - 财政年份:2023
- 资助金额:
$ 28.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Metabolic engineering of Escherichia coli for carbon capture and hydrogen storage.
用于碳捕获和氢储存的大肠杆菌代谢工程。
- 批准号:
2869802 - 财政年份:2023
- 资助金额:
$ 28.23万 - 项目类别:
Studentship
Development of new removal method targeting Escherichia coli causing colorectal cancer
开发针对引起结直肠癌的大肠杆菌的新去除方法
- 批准号:
23K19489 - 财政年份:2023
- 资助金额:
$ 28.23万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Structural Determinants of Permeation Barriers in Escherichia coli
大肠杆菌渗透屏障的结构决定因素
- 批准号:
10749251 - 财政年份:2023
- 资助金额:
$ 28.23万 - 项目类别:
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines
基于轮状病毒的产肠毒素大肠杆菌双重疫苗的研制
- 批准号:
10741541 - 财政年份:2023
- 资助金额:
$ 28.23万 - 项目类别:
A novel genetic switch with an optimal ON/OFF ratio to preserve growth performance prior to Escherichia coli autolysis for enhanced plasmid release
一种具有最佳开/关比的新型基因开关,可在大肠杆菌自溶之前保持生长性能,从而增强质粒释放
- 批准号:
2881246 - 财政年份:2023
- 资助金额:
$ 28.23万 - 项目类别:
Studentship
DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR ANTIMICROBIAL RESISTANCE ESCHERICHIA COLI
大肠杆菌耐药性体外诊断的开发
- 批准号:
10912990 - 财政年份:2023
- 资助金额:
$ 28.23万 - 项目类别: